Table 5. Factors associated with higher levels of cardiovascular risk among patients using protease inhibitors.
| Men (n = 226) | ||||
| Number of Risk Factors | HTN* | SBP≥140 mmHg | DBP≥90 mmHg | |
| Age | 1.51 (0.88–2.60) | 1.80 (0.81–3.98) | 1.99 (0.81–4.91) | 1.99(0.69–5.79) |
| CD4 Count ≥200 | 2.47 (1.21–5.07) | 1.17 (0.42–3.26) | 1.35 (0.43–4.24) | 0.62(0.16–2.35) |
| Days on PI≥540 | 1.66 (0.80–3.43) | 1.82 (0.63–5.27) | 1.62 (0.50–5.20) | 1.62(0.42–6.20) |
| BMI≥25 kg/m2 | - | 4.92 (1.83–13.21) | 5.43 (1.89–15.58) | 5.91 (1.67–20.89) |
Age is a categorical variable defined by three age categories: 16–35, 36–45 and <45 years.
CD4 count is a binary variable: ≥200 and <200 cells/mm3.
BMI was not included as a covariate in the risk factor analysis because BMI≥25 kg/m2 is one of the cardiovascular risk factors.
*
HTN: hypertension.